CHAF1A and neuroblastoma: Our patient data and gain‐of‐function and loss‐of‐function studies in human NB cell lines demonstrated that CHAF1A promotes cell cycle progression and blocks RA‐induced neuronal differentiation, and that CHAF1A impairs differentiation by preventing exit from the cell cycle, thus maintaining the cells in a proliferative state.